TN2010000241A1 - Mequitazine for treating or preventing pathologies involving histamine h4 receptors - Google Patents

Mequitazine for treating or preventing pathologies involving histamine h4 receptors

Info

Publication number: TN2010000241A1
Authority: TN; Tunisia
Prior art keywords: mequitazine; receptors; treating; pathologies involving; involving histamine
Prior art date: 2007-12-04

Application number

TN2010000241A

Other languages

English (en)

Inventor

Thierry Clerc

Christophe Przybylski

Jacky Tisne-Versailles

Didier Cussac

Original Assignee

Pf Medicament

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2007-12-04

Filing date

2010-05-28

Publication date

2011-11-11

2010-05-28 Application filed by Pf Medicament filed Critical Pf Medicament

2011-11-11 Publication of TN2010000241A1 publication Critical patent/TN2010000241A1/fr

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/5415—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with carbocyclic ring systems, e.g. phenothiazine, chlorpromazine, piroxicam
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Epidemiology (AREA)
Pulmonology (AREA)
Dermatology (AREA)
Pain & Pain Management (AREA)
Rheumatology (AREA)
Immunology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicinal Preparation (AREA)

TN2010000241A 2007-12-04 2010-05-28 Mequitazine for treating or preventing pathologies involving histamine h4 receptors TN2010000241A1 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
FR0759538A FR2924344B1 (fr)	2007-12-04	2007-12-04	Utilisation de la mequitazine sous la forme de racemate ou d'enantiomeres pour la preparation d'un medicament destine au traitement ou a la prevention de pathologies impliquant les recepteurs histaminiques h4.
PCT/EP2008/066787 WO2009071625A1 (fr)	2007-12-04	2008-12-04	Utilisation de méquitazine sous sa forme racémate ou énantiomère dans la préparation d'un médicament destiné à traiter ou à prévenir les pathologies impliquant les récepteurs h4 de l'histamine

Publications (1)

Publication Number	Publication Date
TN2010000241A1 true TN2010000241A1 (en)	2011-11-11

Family

ID=39522380

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
TN2010000241A TN2010000241A1 (en)	2007-12-04	2010-05-28	Mequitazine for treating or preventing pathologies involving histamine h4 receptors

Country Status (21)

Country	Link
US (1)	US20100273752A1 (fr)
EP (2)	EP2255811A1 (fr)
JP (2)	JP2011505411A (fr)
KR (1)	KR20100108347A (fr)
CN (1)	CN101883566B (fr)
AR (1)	AR070673A1 (fr)
AU (1)	AU2008333220B2 (fr)
BR (1)	BRPI0820652A2 (fr)
CA (1)	CA2706898A1 (fr)
CL (1)	CL2008003584A1 (fr)
FR (2)	FR2924344B1 (fr)
IL (1)	IL206073A0 (fr)
MA (1)	MA31930B1 (fr)
MX (1)	MX2010006139A (fr)
NZ (1)	NZ586212A (fr)
PA (1)	PA8805501A1 (fr)
RU (1)	RU2510273C2 (fr)
TN (1)	TN2010000241A1 (fr)
TW (1)	TW200932242A (fr)
WO (1)	WO2009071625A1 (fr)
ZA (2)	ZA201004312B (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP2201982A1 (fr)	2008-12-24	2010-06-30	INSERM (Institut National de la Santé et de la Recherche Médicale)	Antagonistes du récepteur H4 de l'histamine pour le traitement de troubles vestibulaires
WO2013182711A1 (fr)	2012-06-08	2013-12-12	Sensorion	Inhibiteurs des récepteurs h4 pour le traitement des acouphènes
EP4163252A1 (fr) *	2021-10-06	2023-04-12	Solvay SA	Procédé de purification d'une solution aqueuse de peroxyde d'hydrogène

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2440371A1 (fr) *	1978-10-31	1980-05-30	Fisons Ltd	Nouveaux composes azotes heterocycliques, des compositions pharmaceutiques en contenant et des procedes pour les preparer
FR2522660A1 (fr) *	1982-03-05	1983-09-09	Pharmuka Lab	Isomere levogyre de la mequitazine, son procede de preparation et medicaments le contenant
JPS6330420A (ja) *	1986-07-25	1988-02-09	Sekisui Chem Co Ltd	持続性抗アレルギ−固形塗布剤
JP2735122B2 (ja) *	1988-06-13	1998-04-02	旭化成工業株式会社	メキタジンの液状シロップ製剤
IT1251161B (it) *	1991-08-07	1995-05-04		Derivati ammonio quaternari di (-) e (+)-3-(10 h-fenotiazin-10-ilmetil)-l-azabiciclo (2.2.2.)ottano e composizioni farmaceutiche che li contengono
DE19653969A1 (de) *	1996-12-20	1998-06-25	Boehringer Ingelheim Kg	Neue wässrige Arzneimittelzubereitung zur Erzeugung treibgasfreier Aerosole
FR2822709B1 (fr) *	2001-03-30	2007-01-19	Antialis	Composition pharmaceutique anti-allergique comprenant au moins un allergene et au moins un compose antihistaminique
DE10158036B4 (de) *	2001-11-27	2007-05-03	Kosmas Kg	Antiallergisches Mittel und dessen Verwendung
WO2004066960A2 (fr) *	2003-01-28	2004-08-12	Schering Corporation	Combinaison d'antagonistes des recepteurs h1, h3 et h4 en vue du traitement d'inflammations pulmonaires allergiques et non allergiques, de congestions et de rhinites allergiques
JP2005060233A (ja) *	2003-08-08	2005-03-10	Rohto Pharmaceut Co Ltd	皮膚外用剤
EP1526135A1 (fr) *	2003-10-24	2005-04-27	Warner-Lambert Company LLC	Azabenzodiazepines utiles comme inhibiteurs de pde4
JPWO2005063253A1 (ja) *	2003-12-26	2007-12-13	大鵬薬品工業株式会社	アレルギー症状治療用医薬組成物
FR2896690B1 (fr) *	2006-01-30	2008-05-02	Pierre Fabre Medicament Sa	Utilisation de l'enantiomere(s) de la mequitazine pour la preparation d'un medicament, tout en limitant la toxicite genomique

2007
- 2007-12-04 FR FR0759538A patent/FR2924344B1/fr not_active Expired - Fee Related
2008
- 2008-06-23 FR FR0854144A patent/FR2924345B1/fr not_active Expired - Fee Related
- 2008-11-26 TW TW097145696A patent/TW200932242A/zh unknown
- 2008-11-27 PA PA20088805501A patent/PA8805501A1/es unknown
- 2008-12-01 CL CL2008003584A patent/CL2008003584A1/es unknown
- 2008-12-04 US US12/746,115 patent/US20100273752A1/en not_active Abandoned
- 2008-12-04 JP JP2010536457A patent/JP2011505411A/ja active Pending
- 2008-12-04 RU RU2010125711/15A patent/RU2510273C2/ru not_active IP Right Cessation
- 2008-12-04 CN CN2008801188010A patent/CN101883566B/zh not_active Expired - Fee Related
- 2008-12-04 BR BRPI0820652A patent/BRPI0820652A2/pt not_active IP Right Cessation
- 2008-12-04 KR KR1020107013817A patent/KR20100108347A/ko not_active Ceased
- 2008-12-04 CA CA2706898A patent/CA2706898A1/fr not_active Abandoned
- 2008-12-04 WO PCT/EP2008/066787 patent/WO2009071625A1/fr not_active Ceased
- 2008-12-04 MX MX2010006139A patent/MX2010006139A/es active IP Right Grant
- 2008-12-04 NZ NZ586212A patent/NZ586212A/xx not_active IP Right Cessation
- 2008-12-04 EP EP10177151A patent/EP2255811A1/fr not_active Withdrawn
- 2008-12-04 AR ARP080105280A patent/AR070673A1/es unknown
- 2008-12-04 EP EP08856761.5A patent/EP2227235B1/fr active Active
- 2008-12-04 AU AU2008333220A patent/AU2008333220B2/en not_active Ceased
2010
- 2010-05-28 TN TN2010000241A patent/TN2010000241A1/fr unknown
- 2010-05-30 IL IL206073A patent/IL206073A0/en unknown
- 2010-06-18 ZA ZA2010/04312A patent/ZA201004312B/en unknown
- 2010-06-22 MA MA32940A patent/MA31930B1/fr unknown
- 2010-10-26 ZA ZA2010/07626A patent/ZA201007626B/en unknown
2013
- 2013-12-04 JP JP2013251130A patent/JP2014065726A/ja active Pending

Also Published As

Publication number	Publication date
HK1148667A1 (en)	2011-09-16
EP2255811A1 (fr)	2010-12-01
AU2008333220B2 (en)	2014-04-24
FR2924345A1 (fr)	2009-06-05
EP2227235A1 (fr)	2010-09-15
AU2008333220A1 (en)	2009-06-11
MA31930B1 (fr)	2010-12-01
IL206073A0 (en)	2010-11-30
EP2227235B1 (fr)	2014-11-12
PA8805501A1 (es)	2009-12-16
FR2924344A1 (fr)	2009-06-05
CL2008003584A1 (es)	2009-05-22
FR2924345B1 (fr)	2010-06-04
CN101883566A (zh)	2010-11-10
JP2014065726A (ja)	2014-04-17
CA2706898A1 (fr)	2009-06-11
ZA201004312B (en)	2011-02-23
CN101883566B (zh)	2013-03-06
TW200932242A (en)	2009-08-01
WO2009071625A1 (fr)	2009-06-11
NZ586212A (en)	2012-09-28
KR20100108347A (ko)	2010-10-06
AR070673A1 (es)	2010-04-28
BRPI0820652A2 (pt)	2019-09-10
FR2924344B1 (fr)	2010-04-16
RU2510273C2 (ru)	2014-03-27
RU2010125711A (ru)	2012-01-10
ZA201007626B (en)	2011-08-31
JP2011505411A (ja)	2011-02-24
US20100273752A1 (en)	2010-10-28
MX2010006139A (es)	2010-10-15

Publication	Publication Date	Title
WO2011014255A8 (fr)	2012-03-15	Traitement de la maladie de crohn au moyen de laquinimod
MX2010013766A (es)	2011-03-15	Rasagilina para modificacion de enfermedad de parkinson.
MX2012004848A (es)	2012-05-29	Compuestos heterociclicos triciclicos.
MX2010009395A (es)	2010-09-24	Agonistas de receptores muscarinicos, composiciones, metodos de tratamiento de los mismos, y procesos para preparacion de los mismos.
IN2012DN02465A (fr)	2015-08-21
TW200745112A (en)	2007-12-16	Tricyclic benzimidazoles and their use as metabotropic glutamate receptor modulators
MX356032B (es)	2018-04-11	Compuestos indola y métodos para tratar el dolor visceral.
PH12017501294A1 (en)	2019-09-09	Compounds, compositions and methods useful for cholesterol mobilisation
WO2008007211A8 (fr)	2009-03-26	Composés de carboxyamide bicycliques à n-bicycloalkyle substitué
MX2010002584A (es)	2010-03-26	Derivados de piperidina como agonistas de receptores muscarinicos.
MX2009004561A (es)	2009-05-11	Derivados de pirazolilo con actividad analgesica y utiles en el tratamiento o profilaxis del dolor.
BRPI0908635B8 (pt)	2021-05-25	composto e/ou um sal farmaceuticamente aceitável do mesmo e composição farmacêutica
BRPI0517438A (pt)	2008-10-07	composto, método para tratar a condição associada com atividade de receptor muscarìnico m4, uso do composto, e, composição farmacêutica
WO2008092072A3 (fr)	2008-11-27	Modulateurs du récepteur métabotropique du glutamate de sous-type 5 et leurs utilisations
MX2010009756A (es)	2010-10-15	Agonistas de receptores muscarinicos, composiciones, metodos de tratamiento de los mismos, y proceso para preparacion de los mismos.
TW200806321A (en)	2008-02-01	New therapeutic combinations for the treatment or prevention of psychotic disorders
WO2007145863A3 (fr)	2008-05-29	Formulation à libération prolongée de naltréxone
MX341660B (es)	2016-08-29	Agonista del receptor de ghrelina para el tratamiento de caquexia.
MX2007006387A (es)	2007-06-20	Derivados de piridina 3-substituidos como antagonistas h3.
TN2010000241A1 (en)	2011-11-11	Mequitazine for treating or preventing pathologies involving histamine h4 receptors
WO2010002835A3 (fr)	2011-04-21	Dérivés de la vinpocétine et de l'éburnamonine favorisant la croissance osseuse
WO2007098090A3 (fr)	2008-11-27	Traitement des maladies hyperprolifératives avec des n-oxydes de modulateurs des récepteurs d'œstrogènes
UA98131C2 (ru)	2012-04-25	Применение 10-[(3r)-1-азабицикло[2.2.2] окт-3-илметил]-10h-фенотиазина для изготовления лекарства для профилактики или лечения недержания мочи
NO20090125L (no)	2009-03-09	Benzimidazolderivater som skal anvendes som antagonist for CB1-reseptor
WO2011094208A3 (fr)	2011-12-15	Procédés et compositions pharmaceutiques pour la prévention et le traitement d'une insuffisance rénale